Gam-COVID-Vac for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Nov 2020: Trial registered, NCT04642339

The trials

NCT04642339: Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela

State
State not given
Phase
Phase 3
People
2,000 planned
Started
Nov 2020
Primary completion
Oct 2021
Arms
Vaccine Gam-COVID-Vac
Results
None posted
  1. 24 Nov 2020: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.